22nd European Meeting on Hypertension and Cardiovascular Protection, 2012 – Londres, Inglaterra.

  •  Berlin questionnaire for screening of obstructive sleep apnea syndrome in patients with resistant hypertension. Muxfeldt, E.S.; Margallo, V.S.; Cavalcanti, A.H.; Gil Salles. Journal of Hypertension; v.30, p.203
  • Different phenotypes of the nat2 gene influences anti-hypertensive hydralazine response in patients with resistant hypertension. Borges, L.S.; Santos Ar; Suffys Pn; Muxfeldt, E.S.; Gil Salles. Journal of Hypertension, v.30, p.e525
  • Nitroglycerin-mediated, but not flow-mediated, vasodilatation is associated with several cardiovascular risk factors in resistant hypertension. Gil Salles; Villela, N.R.; Muxfeldt, E.S. Journal of Hypertension, v.30, p.3476
  • Prevalence of sleep apnea and pattern of ambulatory blood pressure monitoring in patients with resistant hypertension. Muxfeldt, E.S.; Margallo, V.S.; Souza, F.; Cavalcanti, A.H.; Gil Salles. Journal of Hypertension 2012, v.30, p. :e123

 

21st Scientific Meeting of the European Society of Hypertension, 2011, Milão, Itália.

  • Prognostic Importance of Heart Rate and Interaction with Beta-Blocker in Resistant Hypertension. Journal of Hypertension.
  • Reproducibility of Berlin Questionnaire to Evaluate Risk of Sleep Apnea in Patients with Resistant Hypertension. Journal of Hypertension.

 

HBPR 2011 - High Blood Pressure Research - Scientific Sessions, 2011, Orlando, Flórida, USA.

  • Is Home Blood Pressure Monitoring useful to follow-up of patients with resistant hypertension?
  • Prevalence and Associated Factors of Sub-Clinical Hypercortisolism in Patients with Resistant Hypertension.
  • Prognostic Significance of Baseline Heart Rate and its interaction with with Beta-Blocker use in Resistant Hypertension.
  • Which is the ideal interval time to repeat ABPM in patients with white-coat resistant hypertension to assure BP control?

 

23th Scientific Meeting of International Society of Hypertension, 2010, Vancouver, Canadá.

  • A great white coat effect is associated with a better autonomic balance in patients with resistant hypertension.
  • Berlin questionnaire for screening of sleep apnea syndrome in patients with resistant hypertension.
  • Can home blood pressure monitoring replace ambulatory blood pressure monitoring in diagnosis and management of resistant hypertension.
  • Ideal time interval to repeat ambulatory blood pressure monitoring in patients white-coat resistant hypertension.
  • Prognostic Importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension.
  • Prognostic significance of reduced glomerular filtration rate and interaction with microalbuminuria.

 

XVII Congresso Brasileiro de Hipertensão (SBH) e XVIII Scientific Sessions of the Interamerican Society of Hypertension (IASH) - 5 a 8 de agosto de 2009 - Belo Horizonte – MG, Brasil

  • Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
  • Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension.
  • Efficacy of spironolactone therapy in true resistant hypertension diagnosed by Ambulatory Blood Pressure Monitoring.
  • Prognostic importance of the Ambulatory Arterial Stiffness Index for cardiovascular risk stratification in resistant hypertension.
  • Reproducibility of white-coat resistant hypertension diagnosed by Ambulatory Blood Pressure Monitoring.
  • Isolated office hypertension is independently associated with increased central aortic stiffness in hypertensive patients with type 2 diabetes.

 

22nd Scientific Meeting of the International Society of Hypertension and 18th Scientific Meeting of the European Society of Hypertension. Berlim – Alemanha. Em junho de 2008. Apresentação de poster:

  • Assessment of Efficacy of Spironolactone in the treatment of True Resistant Hypertension evaluated by Ambulatory Blood Pressure Monitoring.
  • Non-Dipping Pattern is Independently Associated with Increased Arterial Stiffness in Patients with Resistant Hypertension.
  • Prognostic impact of office and ambulatory blood pressure in patients with resistant hypertension.
  • Relationships between microalbuminuria and 24-hour ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus.
  • Prognostic Value of QTc-Interval duration for Cardiovascular Morbidity and Mortality in patients with Resistant Hypertension.
  • Reproducibility of White-Coat Resistant Hypertension Diagnosed by Ambulatory Blood Pressure Monitoring.
  • Prognostic Importance of the Nocturnal Blood Pressure Reduction in patients with Resistant Hypertension.

 

XVII SCIENTIFIC MEETING OF THE INTER-AMERICAN SOCIETY OF HYPERTENSION. Miami- EUA. Anais do Congresso, 2007.

  • Ambulatory pulse pressure is better correlated to arterial stiffness than the new ambulatory arterial stiffness index in patients with resistant hypertension
  • Pulse pressure and nocturnal blood pressure reduction: which one is a better cardiovascular risk marker in resistant hypertension
  • Relation between left ventricular hypertrophy, systemic inflammation, and endothelial dysfunction in patients with resistant hypertension

 

21st SCIENTIFIC MEETING OF THE INTERNATIONAL SOCIETY OF HYPERTENSION. 5th ASIAN-PACIFIC CONGRESS OF HYPERTENION - Fukuoka - Japão. Anais do Congresso. J. Hypertension, 2006, 24, suppl.2

  • C-Reactive protein distribution in patients with resistant hypertension
  • Factors associated with abnormal T-wave axis deviation in patients with resistant hypertension
  • Pattern of 24-hour ambulatory blood pressure monitoring in type 2 diabetic patients with and without cardiovascular disautonomy
  • Prevalence of primary aldosteronism and computerized tomography findings in adrenal glands in patients with resistant hypertension
  • Factors associated with prolonged transmural dispersion of ventricular repolarization in resistant hypertension

 

WORLD CONGRESS OF CARDIOLOGY 2006. Barcelona - Espanha. Anais do Congresso: European Heart Journal 2006, 27 (suppl.1): p.567.

  • Is Nocturnal blood pressure fall a good cardiovascular risk marker in resistant hypertension?"

 

FIFTEENTH EUROPEAN MEETING ON HYPERTENSION – EUROPEAN SOCIETY OF HYPERTENSION. Milão – Itália. Anais do Congresso:  J. Hypertension, 2005, 23, suppl.2.

  • Medication adherence in Resistant Hypertension: comparing three strategies of evaluation.
  • Cardiovascular factors associated with Microalbuminuria in non-diabetic patients with Resistant Hypertension.

 

20th SCIENTIFIC MEETING OF THE INTERNATIONAL SOCIETY OF HYPERTENSION. São Paulo, Brazil. Anais do Congresso: J. Hypertens, 2004, v.22, supl. 1

  • Predictors of left ventricular hypertrophy in patients with resistant hypertension.
  • Correlates of QT-interval in patients with resistant hypertension: role of left ventricular hypertrophy and geometric  patterns.
  • Assessment of blood pressure control in resistant hypertensive patients with ambulatory blood pressure monitoring.
  • Microalbuminuria and other cardiovascular risk in patients with resistant hypertension.

 

19th SCIENTIFIC MEETING OF THE INTERNATIONAL SOCIETY OF HYPERTENSION. 12th EUROPEAN MEETING ON HYPERTENSION. Praga - República Tcheca. Anais do Congresso: J. Hypertens, jul 2002, v.20, supl. 4.

  • 24-hour ambulatory blood pressure monitoring pattern of resistant hypertension.
  • QT dispersion and resistant hypertension: correlation with echocardiographic, ambulatory blood pressure monitoring and electrocardiographic data.
  • Predictors of left ventricular hypertrophy in patients with resistant hypertension.
  • Predictive factors for resistant hypertension in hypertensive patients under intensive treatment.

 

ELEVENTH EUROPEAN MEETING ON HYPERTENSION DA EUROPEAN SOCIETY OF HYPERTENSION. Milão – Itália. Anais do Congresso: J. Hypertens, jul 2001.

  • The effect of Orlistat + Diet compared with diet alone in anthropometric measures and blood pressure of hypertensive, overweight/obese patients.
  • Prevalence and Characteristics of Resistant Hypertension (RH) and White Coat Effect (WCE) diagnosed by Ambulatory Blood Pressure Monitoring (ABPM).
  • The effect of Orlistat + Diet compared with diet alone in anthropometric measures, glucose and lipids levels of hypertensive, overweight/obese patients.
UFRJ ProHArt - Programa de Hipertensão Arterial
Desenvolvido por: TIC/UFRJ